All Stories

  1. Serum protein binding of antiepileptic drugs
  2. Clinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizures
  3. The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist
  4. New developments in the treatment of partial-onset epilepsy